Cargando…

Effects of Tocilizumab on Inflammation and Iron Metabolism in Critically Ill Patients with COVID-19

COVID-19 produces cytokine-mediated persistent inflammation and is associated with elevated iron stores and low circulating iron. It is believed that central to the pathophysiological mechanism is interleukin 6 and hepcidin. A state of iron overload, termed hyperferritinemia, and inflammatory anemia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szabo, Robert, Petrișor, Cristina, Bodolea, Constantin, Dobre, Vlad, Tranca, Sebastian, Clichici, Simona, Szabo, Iulia, Melinte, Razvan Marian, Mocan, Teodora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960594/ https://www.ncbi.nlm.nih.gov/pubmed/36839968 http://dx.doi.org/10.3390/pharmaceutics15020646

Ejemplares similares

Hyperferritinemia, Low Circulating Iron and Elevated Hepcidin May Negatively Impact Outcome in COVID-19 Patients: A Pilot Study
por: Szabo, Robert, et al.
Publicado: (2022)

Iron, Copper, and Zinc Homeostasis: Physiology, Physiopathology, and Nanomediated Applications
por: Szabo, Robert, et al.
Publicado: (2021)

Clinical versus Ultrasound Measurements of Hyomental Distance Ratio for the Prediction of Difficult Airway in Patients with and without Morbid Obesity
por: Petrișor, Cristina, et al.
Publicado: (2020)

Trends in Molecular Diagnosis of Nosocomial Pneumonia Classic PCR vs. Point-of-Care PCR: A Narrative Review
por: Bălan, Andrei-Mihai, et al.
Publicado: (2023)

Linezolid Administration to Critically Ill Patients: Intermittent or Continuous Infusion? A Systematic Literature Search and Review
por: Hui, Ligia-Ancuta, et al.
Publicado: (2022)

Vesicoureteral Reflux and Innate Immune System: Physiology, Physiopathology, and Clinical Aspects
por: Colceriu, Marius-Cosmin, et al.
Publicado: (2023)

553. Critically Ill patients Receiving Tocilizumab Compared With Those Not Receiving Tocilizumab for Treatment of COVID-19
por: Leonard, Michael, et al.
Publicado: (2020)

Tocilizumab in critically ill COVID-19 patients: An observational study
por: Mushtaq, Muhammad Z., et al.
Publicado: (2022)

Nutritional Risk Assessment Scores Effectively Predict Mortality in Critically Ill Patients with Severe COVID-19
por: Bodolea, Constantin, et al.
Publicado: (2022)

Exploring Patient Adherence to Post-Surgical Follow-Up in Pelvic Endometriosis
por: Szabo, Tamas, et al.
Publicado: (2023)

A fatal case of Taxus poisoning
por: TRANCA, SEBASTIAN, et al.
Publicado: (2013)

Recent Trends in Hydroxyapatite Supplementation for Osteoregenerative Purposes
por: Zastulka, Ana, et al.
Publicado: (2023)

Tocilizumab: An Effective Therapy for Severely and Critically Ill COVID-19 Patients
por: Bhandari, Sudhir, et al.
Publicado: (2021)

Ethinylestradiol(30μg)-drospirenone and metformin: could this combination improve endothelial dysfunction in polycystic ovary syndrome?
por: Ilie, Ioana Rada, et al.
Publicado: (2012)

IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome
por: Dufranc, Etienne, et al.
Publicado: (2020)

The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19
por: Zacharias, Harry, et al.
Publicado: (2022)

Is Tocilizumab Plus Dexamethasone Associated with Superinfection in Critically Ill COVID-19 Patients?
por: Camou, Fabrice, et al.
Publicado: (2022)

Influence of nanomaterials on stem cell differentiation: designing an appropriate nanobiointerface
por: Ilie, Ioana, et al.
Publicado: (2012)

The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill
por: Knight, Jennifer M., et al.
Publicado: (2021)

Tocilizumab Outcomes in Critically Ill COVID-19 Patients Admitted to the ICU and the Role of Non-Tocilizumab COVID-19-Specific Medical Therapeutics
por: Elhazmi, Alyaa, et al.
Publicado: (2023)

Increased Susceptibility to Postoperative PCA Morphine-Induced Respiratory Depression in a Patient with an Undiagnosed Traumatic Porencephalic Cyst – A Case Report
por: Petrișor, Cristina, et al.
Publicado: (2019)

Tocilizumab treatment in critically ill patients with COVID-19: A retrospective observational study
por: Huang, Edmund, et al.
Publicado: (2021)

Tocilizumab in Coronavirus Disease 2019-Related Critical Illness: A Propensity Matched Analysis
por: Rajendram, Prabalini, et al.
Publicado: (2021)

Nicotinamide-functionalized multiwalled carbon nanotubes increase insulin production in pancreatic beta cells via MIF pathway
por: Ilie, Ioana, et al.
Publicado: (2013)

Blue Light—Ocular and Systemic Damaging Effects: A Narrative Review
por: Antemie, Răzvan-Geo, et al.
Publicado: (2023)

Selective ex-vivo photothermal ablation of human pancreatic cancer with albumin functionalized multiwalled carbon nanotubes
por: Mocan, Lucian, et al.
Publicado: (2011)

Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2
por: Petrak, Russell M., et al.
Publicado: (2021)

Treatment Outcomes of Tocilizumab in Critically-Ill COVID-19 Patients, Single-Centre Retrospective Study
por: Hafez, Wael, et al.
Publicado: (2022)

Characterization and In Vitro Biocompatibility of Two New Bioglasses for Application in Dental Medicine—A Preliminary Study
por: Clichici, Andra, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors and the Heart
por: Mocan-Hognogi, Diana Larisa, et al.
Publicado: (2021)

Delayed inflammation decrease is associated with mortality in Tocilizumab-treated critically ill SARS-CoV-2 patients: A retrospective matched-cohort analysis
por: Urbina, Tomas, et al.
Publicado: (2022)

Iron metabolism in critically ill patients developing anemia of inflammation: a case control study
por: Boshuizen, Margit, et al.
Publicado: (2018)

Resolution of cryptogenic new onset refractory status epilepticus with tocilizumab
por: Donnelly, Jonathan P., et al.
Publicado: (2021)

Rational design of gold nanocarrier for the delivery of JAG-1 peptide
por: Matea, Cristian T, et al.
Publicado: (2015)

Treatment of COVID-19 atypical pneumonia by early Tocilizumab administration in “non-critically-ill” patients on hemodialysis
por: Castellano, Giuseppe, et al.
Publicado: (2020)

The Role of Depression and Anxiety in Frail Patients with Heart Failure
por: Hiriscau, Elisabeta Ioana, et al.
Publicado: (2019)

Inflammation characteristics and anti-inflammation treatment with tocilizumab of severe/critical COVID-19 patients: A retrospective cohort study
por: Hu, Qin, et al.
Publicado: (2021)

Invasive fungal infections among critically ill adult COVID-19 patients: First experiences from the national centre in Hungary
por: Szabo, Balint Gergely, et al.
Publicado: (2021)

A Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Effect of Calcium Fructoborate on Systemic Inflammation and Dyslipidemia Markers for Middle-Aged People with Primary Osteoarthritis
por: Scorei, Romulus, et al.
Publicado: (2011)

Exosomes in Colorectal Cancer: From Physiology to Clinical Applications
por: Titu, Stefan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o5sli0p201akv1ml0f09rca6pk